title: Activity of luxabendazole against liver flukes, gastrointestinal roundworms, and lungworms in naturally infected sheep.
abstract: The anthelmintic potential of luxabendazole was investigated in sheep harboring mixed naturally acquired helminth infections. Results were assessed by comparing worm counts of the treated groups (seven animals each) on days 7-8 posttreatment with those of the nontreated control group, except for protostrongylid lungworms, for which the changes in pre- and posttreatment group mean larval counts/g feces were assessed for intensity effect. A single oral treatment at doses of 10.0 or 12.5 mg/kg body wt removed 97.6% of the adult Fasciola hepatica and 63.2%-83.8% of the Dicrocoelium dendriticum. Luxabendazole at 7.5, 10.0, and 12.5 mg/kg proved 100% effective in removing adult worms of the genera Haemonchus, Ostertagia, Trichostrongylus, Cooperia and Nematodirus as well as tissue-associated larval stages of gastrointestinal nematodes of the abomasal mucosa. The drug showed an intensity effect of 79.7%-87.6% against Strongyloides papillosus. Luxabendazole removed all Dictyocaulus filaria and reduced the fecal excretion of larvae of protostrongylid species (Protostrongylus rufescens, Neostrongylus linearis, Cystocaulus ocreatus, Muellerius capillaris) by 97.8%-99.6%. The efficacy of luxabendazole compared favorably with that of Diplin Kombi (oxyclozanide and levamisole), which was used as a reference drug.
authors.affiliation: Department of General Zoology and Parasitology, University of Veterinary Science, Budapest, Hungary.
authors.forename: T
authors.initials: T
authors.lastname: Kassai
authors.forename: C
authors.initials: C
authors.lastname: Takáts
authors.forename: E
authors.initials: E
authors.lastname: Fok
authors.forename: P
authors.initials: P
authors.lastname: Redl
mesh_terms: D000018:Abomasum / Q000469:parasitology; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D004011:Dicrocoeliasis / Q000150:complications / Q000188:drug therapy / Q000662:veterinary; D004022:Dictyocaulus Infections / Q000150:complications / Q000188:drug therapy; D005210:Fasciola hepatica; D005211:Fascioliasis / Q000150:complications / Q000188:drug therapy / Q000662:veterinary; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy; D006374:Helminthiasis, Animal; D007411:Intestinal Diseases, Parasitic / Q000150:complications / Q000188:drug therapy / Q000662:veterinary; D007421:Intestine, Small / Q000469:parasitology; D008099:Liver / Q000469:parasitology; D009349:Nematode Infections / Q000150:complications / Q000188:drug therapy / Q000662:veterinary; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy*
chemical_list: D000871:Anthelmintics; D001562:Benzimidazoles; D002219:Carbamates; C058092:luxabendazole